Global In-vitro Fertilization Microscopes Market Anticipated to Garner $250.4 Million, Growing at a 9.4% CAGR in the 2022-2031 Timeframe | Defined by Research Dive

Global In-vitro Fertilization Microscopes Market Forecast Analysis:

As per the report published by Research Dive, the global in-vitro fertilization microscopes market is expected to register a revenue of $250.4 million by 2031 and grow at a CAGR of 9.4% during the forecast period 2022-2031.

Segments of the In-vitro Fertilization Microscopes Market

The report has divided the in-vitro fertilization microscopes market into the following segments:

  • Type: upright microscope, inverted microscope, stereo microscope, and embryo microscope
    • Embryo Microscope Most profitable in 2021
      The rising importance of embryo microscope to take photos of embryos developed during in-vitro fertilization cycles in an incubator is expected to propel the sub-segment forward.
  • End user: clinical and academic research
    • Clinical – Most lucrative in 2021
      IVF clinics provide a range of services, such as identifying healthy oocytes, ICSI, sperm analysis, embryo monitoring, and freezing and storing of embryos, which is anticipated to push the sub-segment forward.
  • Region: North America, Europe, Asia-Pacific, and LAMEA
    • Europe Significant market share in 2021
      The presence of a large population, improved awareness about IVF, and the availability of IVF services in this region are predicted to propel the regional market growth in the forecast period.

To get access to the Complete PDF Sample of In-vitro Fertilization Microscopes Market Click Here!

Dynamics of the Global In-vitro Fertilization Microscopes Market

Increased public awareness of in-vitro fertilization is expected to make the in-vitro fertilization microscopes market a highly profitable one in the forecast period. Additionally, the growing success rate of in-vitro fertilization techniques and the accessibility of financial resources are predicted to propel the market forward. However, the high price and risks of IVF and ICSI treatments might become a restraint in the growth of the market.

The increased focus on regenerative medicine and nanotechnology research is predicted to offer numerous growth opportunities to the market in the forecast period. Moreover, rising treatment effectiveness as a result of product innovations is expected to propel the in-vitro fertilization microscopes market forward in the coming period.

COVID-19 Impact on the Global In-vitro Fertilization Microscopes Market

The COVID-19 pandemic disrupted the routine lifestyle of people across the globe and the subsequent lockdowns adversely impacted the industrial processes across all sectors. The in-vitro fertilization microscopes market, too, was negatively impacted due to the pandemic. This ultimately reduced demand for microscopes due to supply chain interruptions, the closure of manufacturing companies, and a global economic downturn. In addition, nations that manufacture a significant number of microscopes, including the U.S. and China, were subject to import-export restrictions. These factors significantly hindered the market growth amidst the pandemic.

Check out COVID-19 Impact on In-vitro Fertilization Microscopes Market. Connect with an Expert Analyst or Schedule a call

Key Players of the Global In-vitro Fertilization Microscopes Market

The major players of the market include

  • Olympus Corporation
  • Linkam Scientific Instruments
  • Leica Microsystems
  • Zeiss
  • Euromex Microscopen B.V.
  • Meiji Techno
  • Labomed Europe B.V.
  • Nikon Corporation
  • Eppendorf AG
  • Narishige Group
  • Hamilton Thorne Ltd.

These players are working on developing strategies such as product development, merger and acquisition, partnerships, and collaborations to sustain the market growth.

For instance, in August 2021, Nikon Microscopes, a specialist in microscope-based optical and imaging technology for the life sciences and a member of Nikon Healthcare Business Division, announced ECLIPSE Ti2-U IVF for the primary intracytoplasmic sperm injection (ICSI) treatments.

Request Customization of In-vitro Fertilization Microscopes Market Report as per your Definition and Format & Avail of Amazing Discount

What the Report Covers

Apart from the information summarized in this press release, the final report covers crucial aspects of the market including SWOT analysis, market overview, Porter’s five forces analysis, market dynamics, segmentation (key market trends, forecast analysis, and regional analysis), and company profiles (company overview, operating business segments, product portfolio, financial performance, and latest strategic moves and developments.)

More about In-vitro Fertilization Microscopes Market:

Some Trending Reports:

About Research Dive

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version